NLS Recipharm

The development-stage pharmaceutical company Transpire Bio has announced a definitive agreement with Recipharm to develop TRB-1 and TRB-2, inhaled medicines for the treatment of asthma and Chronic Obstructive Pulmonary Disease (COPD). TRB-1 and TRB-2, the first products developed by Transpire Bio will be indicated for the treatment of asthma and COPD, intended for advanced markets. […]

Recipharm has announced its commitment to helping victims of the conflict in Ukraine. The company is taking steps to provide support to those of its own employees who are directly impacted and to launch a fundraising campaign in which it will match the financial contributions of its staff. “Given the unprovoked invasion of Ukraine and […]

Recipharm has announced the acquisition of Arranta Bio, an advanced therapy CDMO, and Vibalogics, a virotherapy CDMO and a portfolio company of Ampersand Capital Partners. The acquisition of Arranta Bio forms a cornerstone of Recipharm’s strategy to provide innovative drug developers in the biologics market with scientifically differentiated contract development and manufacturing services for ATMPs […]

Recipharm has announced the acquisition of GenIbet, a Portuguese CDMO, specializing in the manufacture of biological clinical trial material and novel modalities such as viral vectors, RNA and microbiome. The acquisition forms part of Recipharm’s strategy to grow in the biologics market, with a particular focus on drug substance manufacturing of novel ATMPs, the company […]

Recipharm has announced the completion of a new analytical laboratory at its facility in Bengaluru, India. The new 370 m2 area is fully cGMP compliant and is equipped with technology and instruments to cater for the rising demand from customers for the company’s stand-alone Recipharm Analytical Solutions, states the company. “It’s great to be able […]

Recipharm has announced investment into a new facility in Uttarakhand, India which will see its fill finish capacity increase to 1 billion sterile units per year. The facility will be constructed on a greenfield site near Dehradun in Uttarakhand and is a joint project between Recipharm and the Sobti family. Read more: Recipharm launches new […]